摘要
肝再生是一个复杂的过程.涉及的细胞类型和再生机制取决于肝损害的程度、损害的类型、基础肝病及全身性反应能力.肝再生能力对于爆发性肝衰竭(FHF)、部分肝切除(PH)后肝容积的恢复起决定性作用.近年的研究表明,白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)既是炎症细胞因子,又是肝再生的重要启动因子.……
出处
《临床肝胆病杂志》
CAS
2006年第5期384-386,共3页
Journal of Clinical Hepatology
参考文献15
-
1Cressman DE,Greenbaum LE,DeAngelis RA,et al.Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice[J].Science,1996,274(22):1379.
-
2Fausto N.Liver Regeneration[J].J Hepatology,2000,32 (1):19-31.
-
3Iwai M,Cui TX,kitamura H,et al.Incraesed Secretion of Tumour Necrosis Factor and Interleukin 6 from Isolated Perfused Liver of Rats After Partial Hepatectomy[J].Cytokine,2002,13 (1):60-64.
-
4Selzner N,Selzer,M,Tian Y,et al.Cold Ischemia Decreases Liver Regeneration After Partial Liver Transplantation in the Rat:A TNF -α/IL-6-Dependent Mechanism[J].Hepatology,2002,36 (2):812 -818.
-
5Aldeguer X,Debonera F,Shaked A,et al.Interleukin-6 From Intrahepatic Cells of Bone Marrow Orgin Is Reguired for Normal Murine Liver Regeneration[J].Hepatology,2002,35 (1):40 -48.
-
6Taub R,Greenrbaum LE,Peng Y.Transcriptional Regulatory Signals Define Cytokine-Dependent and independent Pathway in Liver Regeneration[J].Seminers Liver Disease,1999,19(2):117-127.
-
7Debonera F,Aldeguer X,Shen X,et al.Activation of Interleukin -6/STAT3 and Liver Regeneration Following Transplantation[J].J Surgical Research,2001,96(2):289 -295.
-
8Wuestefeld T,Klein C,Streetz KL,et al.Interleukin-6/Glycoprotein 130-Dependent Pathway Are Protective During Liver Regeneration[J].J Biological Chemistry,2003,278(18):11281-11288.
-
9Kovalovich K,Li W,DeAngelis R,et al.Interleukin -6 Protects against Fas-mediated Death by Establishing a Critical Level of Antiapoptotic Hepatic Proteins FLIp,Bcl-2 and Bcl-XL[J].J Biological Chemistry,2001,276(28):26605 -26613.
-
10Zimmers TA,Mckillop IH,Pierce R,et al.Massive Liver Growth in Mice Induced by Systenic Interleukin-6 Administration[J].Hepatology,2003,38 (2):326-334.
同被引文献37
-
1李国钦,叶报春,高碧华,陈逢梅,庞明.重型肝炎TGF-α、TNF-α、IL-1β改变的初步研究[J].临床肝胆病杂志,2004,20(4):233-235. 被引量:5
-
2无.肝衰竭诊疗指南[J].国际流行病学传染病学杂志,2006,33(4):217-221. 被引量:49
-
3Nguyen MH,Garcia RT,Simpson PW,et al.Ricial differences in effectiveness of α-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.Hepatology,2002,36:410-411
-
4Yusof YAM,Yan KL,Husaain SNA.Immunohistochemical expression of π class glutathione S-transferase and α-fetoprotein in hepatocellular carcinnoma and chronic liver disease.Analytical and Quantitative Cytology and Histology,2003,25(6):332-338
-
5Schmidt LE,Dalhoff R.Aplha-feto-protein is a predictor of outcome in ace taminophen-induced liveringury.Hepatology,2005,41(1):26-31
-
6Fausto N,Campbell JS,Riehle KJ.Liver regeneration.Hepatology,2006,42(Suppl) S 45-53
-
7SANCHEZ A, FCCTOR V M, SCHROEDER I S, et al. Activation of NF-kappaB and STAT3 in rat oval cells during 2-acetylaminoflu orene/partial hepatectomy-induced liver regeneration[J]. Hepatology, 2004, 39(2): 376-385.
-
8AKHURST B, MATI'HEWS V, HUSK K, et al. Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury[J]. Hepatology, 2005, 41(2): 327-335.
-
9HIGGINS G M, ANDERSON R M. Experimental pathology of the liver: restoration of the liver of the white rat following partial surgical removal [J]. Arch Pathol, 1931, 12: 186-202.
-
10AKERMAN P, COTE P, YANG S Q, et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy[J]. Am J Physiol, 1992, 263( 4 Pt 1) : G579-G585.
引证文献4
-
1李国钦,高碧华,叶报春.甲胎蛋白在重型肝炎中改变的分析[J].中西医结合肝病杂志,2007,17(4):198-199. 被引量:4
-
2李存占,张智,段斐,申文增,牛培.LED-蓝光对大鼠肝再生TNF-α、IL-6的影响[J].医学研究与教育,2013,30(1):20-22. 被引量:5
-
3尹梅影,李金强,黎晓武.祛毒退黄汤联合血浆置换治疗对慢性乙肝相关性肝衰竭患者血清细胞因子的影响[J].医学临床研究,2015,32(7):1274-1276. 被引量:4
-
4李金强,黎晓武,杨丽辉,尹梅影,侯琴,肖峻.祛毒退黄汤联合血浆置换治疗乙型肝炎慢加急性肝衰竭患者的临床研究[J].中国医师杂志,2016,18(10):1554-1556. 被引量:3
二级引证文献16
-
1时红波,陈煜,韩大康,赵军,武志明,段钟平.重型肝炎患者血清肝纤维化指标及甲胎蛋白水平的动态变化及其与预后的关系[J].世界华人消化杂志,2008,16(21):2408-2411. 被引量:12
-
2韩晓群,龚慧欣.甲胎蛋白和空腹血糖测定在重症肝炎预后判断中的意义[J].中国中西医结合消化杂志,2009,17(4):260-261. 被引量:2
-
3俞静文.甲胎蛋白检测在重型肝炎中的临床意义[J].中国误诊学杂志,2011,11(19):4595-4595. 被引量:1
-
4郇述玲,王者令,王维科.恩替卡韦治疗甲胎蛋白升高慢性乙型肝炎患者的临床观察[J].中华实验和临床感染病杂志(电子版),2011,5(3):36-38. 被引量:3
-
5孙建钢,刘式浩,董宏伟,侯陈宁,谢盈慧,刘子豪,王欣悦,纪刊,崔妍,李莉.红色LED光源对肝损伤大鼠肝再生影响的研究[J].医学研究与教育,2014,31(2):12-16. 被引量:1
-
6朱晓雯,卢五昌,潘光栋.胰岛素联合肝细胞生长因子对肝切除术后肝再生的促进作用[J].世界华人消化杂志,2016,24(24):3607-3611. 被引量:2
-
7潘光栋,卢五昌,朱晓雯.胰岛素联合肝细胞生长因子对肝切除术后肝再生的促进作用[J].华夏医学,2016,29(5):57-60. 被引量:1
-
8佟静.综合护理干预对人工肝血浆置换术患者的影响[J].社区医学杂志,2017,15(6):47-48. 被引量:2
-
9刘慧敏,毛青.乙型肝炎肝衰竭的预警指标研究及预后效果评价[J].中西医结合肝病杂志,2017,27(2):83-85. 被引量:5
-
10潘光栋,卢五昌,朱晓雯,刘振,刘强,覃创.胰岛素经门静脉灌注促肝切除术后肝再生的临床效果观察[J].广西医学,2017,39(6):888-890. 被引量:1
-
1巫善明,王灵台,王育群.致肝损害的药物种类[J].医药世界,2008(6):85-85.
-
2中草药易发急性药物性肝损伤[J].中国社区医师(医学专业),2008,10(21):215-215.
-
3范玲燕,周智.免疫抑制状态乙型肝炎病毒的再激活及防治[J].中国实用内科杂志,2009,29(1):83-85. 被引量:9
-
4陈小灯,朱敏.暴发性肝炎1例临床分析[J].中国社区医师,2015,31(25):161-161.
-
5肖观清.血浆净化治疗肝衰竭[J].内科急危重症杂志,2013,19(3):138-140. 被引量:2
-
6HiromuT.慢性肝炎炎症活动性对经皮经肝门静脉栓塞后肝再生能力的影响[J].消化外科,1999,1(1):63-63.
-
7刘翠平,邹衍泰,白岚.670例药物性肝损害分析[J].现代消化及介入诊疗,2010,15(6):338-340. 被引量:13
-
8肖春花,利旭辉,张春兰,简希尧.阿德福韦酯治疗慢性乙型肝炎合并非酒精性脂肪性肝病的疗效观察[J].临床肝胆病杂志,2015,31(2):266-268. 被引量:8
-
9张舒宜,丁晓东,范建高.英国非酒精性脂肪性肝炎肝移植指南简介[J].中华肝脏病杂志,2012,20(6):432-433. 被引量:1
-
10王蜀强,江南.免疫抑制剂致乙型肝炎病毒再激活研究进展[J].实用医院临床杂志,2010,7(3):106-108. 被引量:5